We are live on ! Find out more
ELAN icon

Elanco Animal Health

403 hedge funds and large institutions have $5.87B invested in Elanco Animal Health in 2022 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 145 increasing their positions, 142 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more call options, than puts

Call options by funds: $55.3M | Put options by funds: $26M

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

1.31% more ownership

Funds ownership: 100.28%101.59% (+1.3%)

2% more repeat investments, than reductions

Existing positions increased: 145 | Existing positions reduced: 142

1% less capital invested

Capital invested by funds: $5.9B → $5.87B (-$30.3M)

8% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 71

4% less funds holding

Funds holding: 418403 (-15)

Holders
403
Holders Change
-15
Holders Change %
-3.59%
% of All Funds
6.48%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
65
Increased
145
Reduced
142
Closed
71
Calls
$55.3M
Puts
$26M
Net Calls
+$29.3M
Net Calls Change
-$52.9M
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
176
Panagora Asset Management
Massachusetts
$804K +$294K +23,623 +56%
Zurich Cantonal Bank
177
Zurich Cantonal Bank
Switzerland
$802K +$12 +1 +0%
VPIM
178
Vanguard Personalized Indexing Management
California
$801K +$601K +48,209 +278%
Stifel Financial
179
Stifel Financial
Missouri
$798K -$495K -39,677 -38%
CF
180
Covea Finance
France
$794K
GIBU
181
Gulf International Bank (UK)
United Kingdom
$786K
PAG
182
Private Advisor Group
New Jersey
$751K +$323K +25,938 +66%
Aviva
183
Aviva
United Kingdom
$748K -$2.5M -200,187 -77%
DnB Asset Management
184
DnB Asset Management
Norway
$745K -$12.9K -1,034 -2%
VOYA Investment Management
185
VOYA Investment Management
Georgia
$703K +$2.89K +232 +0.4%
QT
186
Quantbot Technologies
New York
$701K +$715K +57,402 New
TMAM
187
Tokio Marine Asset Management
Japan
$697K +$48.6K +3,900 +7%
GH
188
GAM Holding
Switzerland
$670K +$250K +20,073 +58%
OPERF
189
Oregon Public Employees Retirement Fund
Oregon
$620K +$632K +50,707 New
Envestnet Asset Management
190
Envestnet Asset Management
Illinois
$615K -$4.13M -331,575 -87%
NAM
191
Nissay Asset Management
Japan
$607K +$13.4K +1,074 +2%
BCM
192
Bayesian Capital Management
New York
$595K +$607K +48,700 New
Verition Fund Management
193
Verition Fund Management
Connecticut
$588K -$942K -75,566 -61%
Teacher Retirement System of Texas
194
Teacher Retirement System of Texas
Texas
$578K -$169K -13,544 -22%
HAM
195
Hedges Asset Management
Nevada
$567K -$232K -18,600 -29%
DTL
196
Dynamic Technology Lab
Singapore
$564K -$55.6K -4,457 -9%
EI
197
Ethic Inc
New York
$556K +$240K +19,272 +74%
Mariner
198
Mariner
Kansas
$544K -$143K -11,440 -20%
AB
199
Amalgamated Bank
New York
$540K
Handelsbanken Fonder
200
Handelsbanken Fonder
Sweden
$514K -$3.9M -312,775 -88%

ELAN Hedge Fund Activity: Q4 2022 in Review

403 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q4 2022, worth a combined $5.87B — down 0.51% from $5.9B a quarter earlier.

Sellers outnumbered buyers: 71 funds closed out of ELAN and 65 opened new positions — a net loss of 6 holders — while 142 trimmed existing stakes and 145 added.

The largest buyer was Dodge & Cox, adding an estimated $396M. The largest seller was Sachem Head Capital Management, cutting an estimated $314M.

  • 403 institutional investors held Elanco Animal Health (ELAN) as of Q4 2022, down from 418 in Q3 2022.
  • Funds reported $5.87B of Elanco Animal Health stock for Q4 2022, down 0.51% quarter-over-quarter.
  • 65 funds opened new Elanco Animal Health positions in Q4 2022 and 71 closed out, a net change of -6 holders.
  • The largest Elanco Animal Health buyer in Q4 2022 was Dodge & Cox, an estimated $396M added.
  • The largest Elanco Animal Health seller in Q4 2022 was Sachem Head Capital Management, an estimated $314M sold.

Based on aggregated 13F filings for Q4 2022.